Great West Life Assurance Co. Can reduced its stake in Clorox Company (The) (NYSE:CLX) by 31.4% during the second quarter, Holdings Channel reports. The institutional investor owned 185,997 shares of the company’s stock after selling 84,953 shares during the period. Great West Life Assurance Co. Can’s holdings in Clorox Company (The) were worth $24,748,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of the company. Macquarie Group Ltd. boosted its stake in shares of Clorox Company (The) by 6.5% in the fourth quarter. Macquarie Group Ltd. now owns 6,600 shares of the company’s stock valued at $792,000 after buying an additional 400 shares in the last quarter. Manning & Napier Advisors LLC boosted its stake in shares of Clorox Company (The) by 7.1% in the first quarter. Manning & Napier Advisors LLC now owns 22,261 shares of the company’s stock valued at $3,001,000 after buying an additional 1,478 shares in the last quarter. Fulton Bank N.A. purchased a new stake in shares of Clorox Company (The) during the first quarter valued at $219,000. Creative Planning boosted its stake in shares of Clorox Company (The) by 0.8% in the first quarter. Creative Planning now owns 14,479 shares of the company’s stock valued at $1,952,000 after buying an additional 116 shares in the last quarter. Finally, Gulf International Bank UK Ltd boosted its stake in shares of Clorox Company (The) by 1.5% in the first quarter. Gulf International Bank UK Ltd now owns 40,336 shares of the company’s stock valued at $5,438,000 after buying an additional 600 shares in the last quarter. Institutional investors and hedge funds own 70.29% of the company’s stock.

Clorox Company (NYSE CLX) opened at 134.21 on Thursday. Clorox Company has a 12 month low of $111.24 and a 12 month high of $141.76. The firm has a market capitalization of $17.29 billion, a price-to-earnings ratio of 26.51 and a beta of 0.40. The company’s 50-day moving average price is $133.88 and its 200 day moving average price is $133.46.

Clorox Company (The) (NYSE:CLX) last announced its quarterly earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.49 by $0.04. The company had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.65 billion. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. Clorox Company (The)’s revenue for the quarter was up 2.9% on a year-over-year basis. During the same period in the previous year, the business earned $1.30 EPS. Analysts predict that Clorox Company will post $5.68 EPS for the current year.

ILLEGAL ACTIVITY WARNING: This news story was reported by Daily Political and is the sole property of of Daily Political. If you are viewing this news story on another site, it was illegally copied and reposted in violation of U.S. and international trademark and copyright legislation. The correct version of this news story can be accessed at https://www.dailypolitical.com/2017/08/10/great-west-life-assurance-co-can-lowers-stake-in-clorox-company-the-clx.html.

CLX has been the subject of several research reports. Jefferies Group LLC initiated coverage on Clorox Company (The) in a report on Tuesday, April 18th. They issued a “hold” rating and a $138.00 target price for the company. Vetr cut Clorox Company (The) from a “buy” rating to a “hold” rating and set a $139.67 target price for the company. in a report on Tuesday, April 18th. Royal Bank Of Canada set a $115.00 target price on Clorox Company (The) and gave the stock a “hold” rating in a report on Monday, April 24th. BMO Capital Markets reiterated a “buy” rating and issued a $136.00 target price on shares of Clorox Company (The) in a report on Thursday, May 4th. Finally, UBS AG reiterated a “sell” rating and issued a $121.00 target price (up from $117.00) on shares of Clorox Company (The) in a report on Friday, May 5th. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating and three have given a buy rating to the company’s stock. Clorox Company (The) currently has an average rating of “Hold” and an average price target of $129.05.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.